These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 39430835)
21. 5'tiRNA-Pro-TGG, a novel tRNA halve, promotes oncogenesis in sessile serrated lesions and serrated pathway of colorectal cancer. Wang XY; Zhou YJ; Chen HY; Chen JN; Chen SS; Chen HM; Li XB World J Gastrointest Oncol; 2023 Jun; 15(6):1005-1018. PubMed ID: 37389118 [TBL] [Abstract][Full Text] [Related]
22. Overexpressed PAQR4 predicts poor overall survival and construction of a prognostic nomogram based on PAQR family for hepatocellular carcinoma. Qu C; Ma T; Yan X; Li X; Li Y Math Biosci Eng; 2022 Jan; 19(3):3069-3090. PubMed ID: 35240821 [TBL] [Abstract][Full Text] [Related]
23. The Prognostic and Drug-targeting Value of Lymphoid Enhancer-binding Factor-1 in Hepatocellular Carcinoma. Guo R; Dai H; Liu F; Liu M; Li X; Li T; Liao J; Chen ZS; Liu Y; Fang S Recent Pat Anticancer Drug Discov; 2022; 18(2):211-223. PubMed ID: 36045537 [TBL] [Abstract][Full Text] [Related]
24. Identification of Seven-Gene Hypoxia Signature for Predicting Overall Survival of Hepatocellular Carcinoma. Bai Y; Qi W; Liu L; Zhang J; Pang L; Gan T; Wang P; Wang C; Chen H Front Genet; 2021; 12():637418. PubMed ID: 33912215 [TBL] [Abstract][Full Text] [Related]
25. Unveiling the role of tRNA-derived small RNAs in MAPK signaling pathway: implications for cancer and beyond. Wang Q; Huang Q; Ying X; Shen J; Duan S Front Genet; 2024; 15():1346852. PubMed ID: 38596214 [TBL] [Abstract][Full Text] [Related]
26. Fatty acid metabolism affects hepatocellular carcinoma progression via the PPAR-γ signaling pathway and fatty acid β-oxidation. Feng W; Liang J; Xu B; Huang L; Xu Q; Chen D; Lai J; Chen J Int Immunopharmacol; 2024 Nov; 141():112917. PubMed ID: 39137630 [TBL] [Abstract][Full Text] [Related]
27. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma. Wang S; Bai H; Fei S; Miao B Biochem Genet; 2024 Jun; 62(3):2332-2351. PubMed ID: 37898914 [TBL] [Abstract][Full Text] [Related]
28. A 5`-tRNA Derived Fragment NamedtiRNA-Val-CAC-001 Works as a Suppressor in Gastric Cancer. Zheng J; Li C; Zhu Z; Yang F; Wang X; Jiang P; Yan F Cancer Manag Res; 2022; 14():2323-2337. PubMed ID: 35958946 [TBL] [Abstract][Full Text] [Related]
29. Maternal Serum tRNA-Derived Fragments (tRFs) as Potential Candidates for Diagnosis of Fetal Congenital Heart Disease. Lu E; Wu L; Chen B; Xu S; Fu Z; Wu Y; Wu Y; Gu H J Cardiovasc Dev Dis; 2023 Feb; 10(2):. PubMed ID: 36826574 [TBL] [Abstract][Full Text] [Related]
30. An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients. Zhu G; Xia H; Tang Q; Bi F Cancer Cell Int; 2021 Mar; 21(1):166. PubMed ID: 33712026 [TBL] [Abstract][Full Text] [Related]
31. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma. Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y Front Oncol; 2023; 13():1144269. PubMed ID: 37056349 [TBL] [Abstract][Full Text] [Related]
32. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma. Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652 [TBL] [Abstract][Full Text] [Related]
33. DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma. Lu Y; Wang S; Chi T; Zhao Y; Guo H; Wang H; Feng L Sci Rep; 2023 Nov; 13(1):18978. PubMed ID: 37923899 [TBL] [Abstract][Full Text] [Related]
34. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma. Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790 [TBL] [Abstract][Full Text] [Related]
35. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma. Xiao Y; Li J; Wu J BMC Med Genomics; 2023 Jul; 16(1):177. PubMed ID: 37525171 [TBL] [Abstract][Full Text] [Related]
36. [Overexpression of Nei endonuclease VIII-like protein 3 in hepatocellular carcinoma indicates increased levels of immune infiltration and an unfavorable prognosis]. Wang GN; Zhang YP; Wang MC; Han W; Zhang YC Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):986-995. PubMed ID: 37872095 [No Abstract] [Full Text] [Related]
37. Expression of tiRNA and tRF in Lu H; Liu L; Han S; Wang B; Qin J; Bu K; Zhang Y; Li Z; Ma L; Tian J; Zhang K; Li T; Cui H; Liu X Ann Transl Med; 2021 Sep; 9(18):1457. PubMed ID: 34734009 [TBL] [Abstract][Full Text] [Related]
38. A Novel Prognostic Model of Hepatocellular Carcinoma per Two NAD+ Metabolic Synthesis-Associated Genes. Dai L; Lu S; Mao L; Zhong M; Feng G; He S; Yuan G Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408693 [TBL] [Abstract][Full Text] [Related]
39. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma. Chen S; Zhao E Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631 [TBL] [Abstract][Full Text] [Related]
40. tiRNAs as a novel biomarker for cell damage assessment in in vitro ischemia-reperfusion model in rat neuronal PC12 cells. Elkordy A; Rashad S; Shehabeldeen H; Mishima E; Niizuma K; Abe T; Tominaga T Brain Res; 2019 Jul; 1714():8-17. PubMed ID: 30779912 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]